# Saint Luke's Hospital of Kansas City Blood Bank – FDA Inspection, Mar 16, 2016

Source: https://www.keypedia.com/records/fda_inspections/saint-lukes-hospital-of-kansas-city-blood-bank/58cb0f94-4750-4cfa-be90-71643fa97214
Source feed: FDA_Inspections

> FDA inspection 962359 of Saint Luke's Hospital of Kansas City Blood Bank, March 16, 2016. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 962359
- Company Name: Saint Luke's Hospital of Kansas City Blood Bank
- Inspection Date: 2016-03-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1275693 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/saint-lukes-hospital-of-kansas-city-blood-bank/1c17392d-13c8-40b8-80ff-f99a2c36df99)
- FDA Inspection 1163560 - 2022-02-28
- [FDA Inspection 1045890 - 2018-02-28](https://www.keypedia.com/records/fda_inspections/saint-lukes-hospital-of-kansas-city-blood-bank/952b4b18-4d8a-48fe-a24f-c10d22f6286b)
- FDA Inspection 884528 - 2014-06-25
- FDA Inspection 822156 - 2013-03-13

Company: https://www.keypedia.com/companies/saint-lukes-hospital-of-kansas-city-blood-bank/f8f0670d-ad9d-4e7b-a544-262fd24fd5b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d